Unum Group (NYSE:UNM) Given a $89.00 Price Target at UBS Group

Unum Group (NYSE:UNM - Get Free Report) has been assigned a $89.00 price target by equities research analysts at UBS Group in a research note issued to investors on Friday, Marketbeat reports. The brokerage presently has a "neutral" rating on the financial services provider's stock. UBS Group's target price indicates a potential upside of 10.52% from the company's current price.

Several other research analysts also recently commented on the stock. Piper Sandler raised their price target on shares of Unum Group from $87.00 to $92.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Raymond James upgraded shares of Unum Group from a "market perform" rating to a "strong-buy" rating and set a $108.00 target price on the stock in a research report on Wednesday, March 5th. Morgan Stanley upped their price objective on shares of Unum Group from $76.00 to $83.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Keefe, Bruyette & Woods lowered their price objective on shares of Unum Group from $103.00 to $102.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Finally, Barclays boosted their price target on shares of Unum Group from $85.00 to $89.00 and gave the company an "overweight" rating in a research report on Friday, April 11th. Five equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Unum Group presently has an average rating of "Moderate Buy" and a consensus price target of $88.29.

Unum Group Stock Performance

Unum Group stock traded down $1.21 during mid-day trading on Friday, reaching $80.53. The company's stock had a trading volume of 854,439 shares, compared to its average volume of 1,316,502. Unum Group has a 12-month low of $48.38 and a 12-month high of $84.48. The company has a market capitalization of $14.04 billion, a P/E ratio of 8.50, a PEG ratio of 1.14 and a beta of 0.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.28 and a current ratio of 0.29. The firm's fifty day moving average price is $78.70 and its two-hundred day moving average price is $76.47.

Unum Group (NYSE:UNM - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The financial services provider reported $2.04 earnings per share for the quarter, missing analysts' consensus estimates of $2.19 by ($0.15). Unum Group had a net margin of 13.81% and a return on equity of 14.91%. The business had revenue of $3.09 billion during the quarter, compared to analysts' expectations of $3.34 billion. During the same quarter in the prior year, the firm posted $2.12 earnings per share. The firm's quarterly revenue was down 3.4% on a year-over-year basis. Sell-side analysts predict that Unum Group will post 9.14 EPS for the current fiscal year.

Unum Group declared that its Board of Directors has initiated a stock repurchase program on Tuesday, February 18th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to reacquire up to 7.4% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board believes its stock is undervalued.

Insider Transactions at Unum Group

In other Unum Group news, EVP Lisa G. Iglesias sold 7,000 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $82.75, for a total value of $579,250.00. Following the transaction, the executive vice president now directly owns 31,284 shares in the company, valued at approximately $2,588,751. This trade represents a 18.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Elizabeth Claire Ahmed sold 10,000 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $80.00, for a total transaction of $800,000.00. Following the completion of the transaction, the executive vice president now owns 51,170 shares in the company, valued at $4,093,600. The trade was a 16.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 67,000 shares of company stock worth $5,478,750. Corporate insiders own 0.93% of the company's stock.

Institutional Trading of Unum Group

Institutional investors and hedge funds have recently modified their holdings of the company. Barrett & Company Inc. lifted its position in shares of Unum Group by 300.0% in the fourth quarter. Barrett & Company Inc. now owns 396 shares of the financial services provider's stock worth $29,000 after buying an additional 297 shares in the last quarter. Vermillion & White Wealth Management Group LLC bought a new stake in Unum Group in the first quarter worth about $30,000. N.E.W. Advisory Services LLC purchased a new position in Unum Group during the 1st quarter valued at $35,000. Kestra Investment Management LLC purchased a new stake in Unum Group in the fourth quarter worth $38,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Unum Group by 196.9% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 478 shares of the financial services provider's stock worth $39,000 after purchasing an additional 317 shares during the period. 86.57% of the stock is currently owned by institutional investors.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.